Customer Update: 23andMe reaches out to "genetic pioneers"

As I continue to follow the fate of 23andMe, here's an email the company sent to its existing customers last week:  Dear 23andMe Customers, I'm writing to update you on our conversation with the U.S. Food and Drug Administration and how it impacts you. If you are a customer whose kit was purchased before November 22, 2013, your 23andMe experience will not change. You will be able to access both ancestry and health-related information as you always have. 23andMe has complied with the FDA's directive and stopped offering new consumers access to health-related genetic results while the company moves forward with the agency's regulatory review processes. Be sure to refer to our 23andMe blog for updates. We stand behind the data we have generated for customers. Our lab partner adheres to strict quality standards that are part of the Clinical Laboratory Improvement Amendments of 1988 - known as CLIA. These are the same standards used in the majority of other health and disease-related tests. You are among the first people in the world to ever get access to their genomes. You are genetic pioneers. Thank you for your ongoing support and we look forward to continuing to serve you. Anne Wojcicki Co-founder and CEO, 23andMe